Chargement en cours...
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
Despite advances in treatments and improved survival, patients with pulmonary hypertension still experience poor exercise and functional capacity, which has a significant detrimental impact on their quality of life. The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine 3′,5′-monopho...
Enregistré dans:
| Publié dans: | Drug Des Devel Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5402909/ https://ncbi.nlm.nih.gov/pubmed/28458514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S117277 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|